FDA Approves Aegerion Cholesterol Drug

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Aegerion Pharmaceuticals (Nasdaq: AEGR  ) has received its first approval from the Food and Drug Administration, the company announced in a press release. The FDA gave the nod to the firm's Juxtapid, a drug that combats a rare genetic cholesterol disorder called homozygous familiar hypercholesterolemia.

According to The Wall Street Journal, around 3,000 patients in the U.S. are eligible to use the medication. It is expected to cost $200,000-$300,000 per year for a prescription. Since Juxtapid carries a risk of liver toxicity, the FDA is requiring the company to ship it with warning labels addressing that fact.

Aegerion will begin the sales process for Juxtapid in January.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2168402, ~/Articles/ArticleHandler.aspx, 5/25/2016 7:16:32 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 10 hours ago Sponsored by:
DOW 17,706.05 213.12 1.22%
S&P 500 2,076.06 28.02 1.37%
NASD 4,861.06 95.27 2.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/24/2016 4:00 PM
AEGR $1.64 Down +0.00 +0.00%
Aegerion Pharmaceu… CAPS Rating: **